Accéder au contenu
Merck

Identification of SERPINB1 as a physiological inhibitor of human granzyme H.

Journal of immunology (Baltimore, Md. : 1950) (2012-12-28)
Li Wang, Qian Li, Lianfeng Wu, Shengwu Liu, Yong Zhang, Xuan Yang, Pingping Zhu, Honglian Zhang, Kai Zhang, Jizhong Lou, Pingsheng Liu, Liang Tong, Fei Sun, Zusen Fan
RÉSUMÉ

The granzyme/perforin pathway is a major mechanism for cytotoxic lymphocytes to eliminate virus-infected and tumor cells. The balance between activation and inhibition of the proteolytic cascade must be tightly controlled to avoid self damage. Granzyme H (GzmH) is constitutively expressed in NK cells and induces target cell death; however, how GzmH activity is regulated remains elusive. We reported earlier the crystal structures of inactive D102N-GzmH alone and in complex with its synthetic substrate and inhibitor, as well as defined the mechanisms of substrate recognition and enzymatic activation. In this study, we identified SERPINB1 as a potent intracellular inhibitor for GzmH. Upon cleavage of the reactive center loop at Phe(343), SERPINB1 forms an SDS-stable covalent complex with GzmH. SERPINB1 overexpression suppresses GzmH- or LAK cell-mediated cytotoxicity. We determined the crystal structures of active GzmH and SERPINB1 (LM-DD mutant) in the native conformation to 3.0- and 2.9-Å resolution, respectively. Molecular modeling reveals the possible conformational changes in GzmH for the suicide inhibition. Our findings provide new insights into the inhibitory mechanism of SERPINB1 against human GzmH.